Salarius Pharmaceuticals Inc (SLRX)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -49.901 | -70.125 | -96.609 | -57.124 | -39.917 | -38.829 | -113.933 | -118.118 |
| Return on Equity (%) | -52.133 | -77.885 | -114.21 | -69.835 | -47.337 | -41.943 | -128.729 | -160.069 |
| Return on Invested Capital (%) | -53.582 | -78.83 | -115.383 | -84.526 | -48.389 | -43.553 | -97.391 | -166.667 |
| Operating Margin (%) | -3906.33 | -2702.826 | -2615.99 | -200.231 | -140.436 | -693.913 | N/A | N/A |
| Net Profit Margin (%) | -3906.33 | -2702.826 | -2615.99 | -200.173 | -148.079 | -693.913 | N/A | N/A |
| Book Value Per Share | 3.536 | 1.635 | 0.514 | 0.38 | 0.558 | 0.66 | 4.603 | 1.343 |
| Earnings Per Share | -2.354 | -1.935 | -1.213 | -1.538 | -0.325 | -0.282 | -14.011 | -3.185 |
| Cash Per Share | 1.336 | 1.078 | 0.544 | 0.829 | 0.467 | 0.646 | 5.366 | 1.498 |
| Working Capital Per Share | 3.492 | 1.612 | 0.51 | 0.306 | 0.547 | 0.62 | 4.545 | 1.326 |
| Operating Profit Per Share | 0.037 | 0.061 | 0.035 | 0.768 | 0.22 | 0.041 | N/A | N/A |
| EBIT Per Share | -2.354 | -1.935 | -1.213 | -1.538 | -0.309 | -0.282 | -14.011 | -3.185 |
| EBITDA Per Share | -2.354 | -1.935 | -1.213 | -1.538 | -0.309 | -0.282 | -14.011 | -3.185 |
| Free Cash Flow Per Share | -2.338 | -1.947 | -1.226 | -1.544 | -0.326 | -0.283 | -13.349 | -3.188 |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 16.77M | 17.8M | 18.07M | 4.51M | 23.81M | 45.24M | 2.26M | N/A |
| Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Shares Outstanding | 2.26M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 1.42M |
| Price to Earnings Ratio | -0.11 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.23 |
| Price to Book Ratio | 0.25 |
| Dividend Yield | - |
| Shares Outstanding | 1.44M |
| Average Volume (1 week) | 45.26k |
| Average Volume (1 Month) | 197.54k |
| 52 Week Change | -83.15% |
| 52 Week High | 7.20 |
| 52 Week Low | 0.906 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
